Who
Gregory Burshtein
Chief of R&D
Company insider
Files Form 4 as: Chief of R&D, Entera Bio.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Jul 2025
- Last trade
- 7 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Aug 2026filed 7 Aug 2026 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —180,000 at $0.00 | filing |
| 7 Aug 2026filed 7 Aug 2026 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —180,000 at $0.00 | filing |
| 7 May 2026filed 8 May 2026 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —87,591 at $0.00 | filing |
| 7 May 2026filed 8 May 2026 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —87,591 at $0.00 | filing |
| 16 Jul 2025filed 18 Jul 2025 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 16 Jul 2025filed 18 Jul 2025 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —26,316 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.